Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic2
|
ENSMUSG00000050240.8 | hypermethylated in cancer 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_17233695_17234415 | Hic2 | 391 | 0.475311 | 0.58 | 4.1e-06 | Click! |
chr16_17225709_17225888 | Hic2 | 7774 | 0.094039 | -0.52 | 4.9e-05 | Click! |
chr16_17243810_17244027 | Hic2 | 10254 | 0.096532 | -0.50 | 1.2e-04 | Click! |
chr16_17249267_17249459 | Hic2 | 15699 | 0.091737 | -0.38 | 4.3e-03 | Click! |
chr16_17252281_17252454 | Hic2 | 18703 | 0.089044 | -0.31 | 2.0e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 122.80 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_124439906_124440949 | 58.06 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr14_14350947_14351733 | 58.01 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr2_153425549_153426538 | 41.42 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr10_81559146_81561402 | 37.10 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr19_61225302_61226760 | 35.16 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr14_14349938_14350878 | 34.05 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr5_133453797_133453985 | 33.25 |
Gm42625 |
predicted gene 42625 |
10549 |
0.22 |
chr1_20819843_20820501 | 32.96 |
Mcm3 |
minichromosome maintenance complex component 3 |
88 |
0.93 |
chr10_17983401_17983568 | 30.18 |
Gm17711 |
predicted gene, 17711 |
27784 |
0.15 |
chr4_82494936_82495219 | 29.90 |
Nfib |
nuclear factor I/B |
4239 |
0.24 |
chr10_62194485_62194811 | 29.79 |
Mir7662 |
microRNA 7662 |
421 |
0.47 |
chr14_55052682_55052968 | 29.32 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
1044 |
0.27 |
chr13_73704941_73705129 | 28.99 |
Slc6a19 |
solute carrier family 6 (neurotransmitter transporter), member 19 |
170 |
0.91 |
chr3_88232209_88232744 | 28.95 |
Gm3764 |
predicted gene 3764 |
3693 |
0.1 |
chr3_88214175_88214875 | 28.92 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr3_85300020_85300198 | 28.78 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17410 |
0.24 |
chr1_34666183_34666826 | 28.41 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
11684 |
0.13 |
chr14_24617341_24617911 | 28.29 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr2_33130296_33131698 | 28.26 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr12_112721309_112722969 | 28.25 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr8_111614648_111614989 | 27.93 |
Znrf1 |
zinc and ring finger 1 |
5522 |
0.17 |
chr1_133181035_133181537 | 27.00 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
35 |
0.98 |
chr12_30372910_30373696 | 26.72 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr12_56415275_56415462 | 26.32 |
Gm18027 |
predicted gene, 18027 |
4811 |
0.2 |
chr18_42740241_42740444 | 25.93 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
117883 |
0.05 |
chr4_148867978_148868414 | 25.79 |
Casz1 |
castor zinc finger 1 |
21185 |
0.18 |
chr15_85652871_85653067 | 25.08 |
Lncppara |
long noncoding RNA near Ppara |
647 |
0.66 |
chr4_39344371_39344735 | 24.52 |
Gm23607 |
predicted gene, 23607 |
49090 |
0.15 |
chr14_123626303_123627238 | 24.45 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr11_31767896_31768473 | 24.44 |
D630024D03Rik |
RIKEN cDNA D630024D03 gene |
56289 |
0.11 |
chr9_16484808_16485485 | 23.90 |
Fat3 |
FAT atypical cadherin 3 |
16139 |
0.27 |
chr1_155209984_155210436 | 23.67 |
BC034090 |
cDNA sequence BC034090 |
3771 |
0.18 |
chr1_167608265_167608743 | 23.60 |
Rxrg |
retinoid X receptor gamma |
9805 |
0.27 |
chr7_4123736_4124170 | 23.38 |
Ttyh1 |
tweety family member 1 |
536 |
0.57 |
chr16_38955368_38955688 | 23.31 |
Gm22500 |
predicted gene, 22500 |
28319 |
0.18 |
chr4_100913798_100913949 | 23.19 |
Cachd1 |
cache domain containing 1 |
80738 |
0.09 |
chr6_91284995_91285433 | 23.13 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr7_49922872_49923348 | 22.86 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
11410 |
0.25 |
chr18_35019023_35019721 | 22.76 |
Gm36037 |
predicted gene, 36037 |
36402 |
0.11 |
chr13_83985066_83985623 | 22.55 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr14_19042458_19042951 | 22.44 |
Gm48781 |
predicted gene, 48781 |
480 |
0.71 |
chr8_72646405_72646797 | 22.38 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
110 |
0.96 |
chr7_31127074_31128340 | 22.38 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr6_55676658_55677265 | 22.33 |
Neurod6 |
neurogenic differentiation 6 |
4302 |
0.26 |
chr11_24129398_24130415 | 22.29 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
12473 |
0.15 |
chr7_46509699_46510289 | 22.23 |
Gm45311 |
predicted gene 45311 |
2786 |
0.23 |
chr3_80800657_80801686 | 22.23 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
1408 |
0.52 |
chr16_84042025_84042426 | 22.21 |
Gm41481 |
predicted gene, 41481 |
15159 |
0.29 |
chr5_38158989_38159808 | 22.19 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr2_66634450_66635011 | 22.06 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
77 |
0.98 |
chr16_35613873_35614640 | 22.05 |
Gm5963 |
predicted pseudogene 5963 |
40700 |
0.13 |
chr1_34583668_34584368 | 21.98 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
4307 |
0.1 |
chr3_146397357_146397698 | 21.79 |
Gm22901 |
predicted gene, 22901 |
1690 |
0.26 |
chr10_74922677_74923156 | 21.57 |
Gnaz |
guanine nucleotide binding protein, alpha z subunit |
44261 |
0.14 |
chr15_4375774_4376213 | 21.53 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
489 |
0.88 |
chr8_94567491_94567722 | 21.40 |
Cpne2 |
copine II |
4956 |
0.14 |
chr14_55054973_55055741 | 21.29 |
Gm20687 |
predicted gene 20687 |
136 |
0.88 |
chr10_26695225_26695646 | 21.13 |
Gm48893 |
predicted gene, 48893 |
139 |
0.96 |
chr1_91209751_91210137 | 21.09 |
Ramp1 |
receptor (calcitonin) activity modifying protein 1 |
29898 |
0.11 |
chr7_44310178_44311500 | 20.86 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr2_154223254_154223780 | 20.80 |
Bpifb5 |
BPI fold containing family B, member 5 |
225 |
0.91 |
chr11_6606254_6606619 | 20.67 |
Nacad |
NAC alpha domain containing |
383 |
0.7 |
chr10_59092115_59092323 | 20.65 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
12185 |
0.23 |
chr11_115496116_115496547 | 20.63 |
Gm11694 |
predicted gene 11694 |
3307 |
0.1 |
chr5_84848501_84849167 | 20.59 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr16_91962945_91963627 | 20.49 |
Gm27773 |
predicted gene, 27773 |
19138 |
0.1 |
chr4_91371091_91372260 | 20.30 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chr1_173365799_173366481 | 20.30 |
Cadm3 |
cell adhesion molecule 3 |
1493 |
0.35 |
chr12_3930272_3930423 | 20.22 |
Gm9088 |
predicted gene 9088 |
1693 |
0.3 |
chr4_154948181_154948553 | 20.20 |
Hes5 |
hes family bHLH transcription factor 5 |
12556 |
0.11 |
chr11_3132475_3133419 | 20.15 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
3060 |
0.17 |
chr13_99443818_99444236 | 20.07 |
Map1b |
microtubule-associated protein 1B |
83 |
0.97 |
chr14_55054195_55054444 | 20.07 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
372 |
0.55 |
chr1_38450635_38451180 | 19.94 |
Gm34727 |
predicted gene, 34727 |
36612 |
0.18 |
chr9_101404472_101405037 | 19.88 |
Gm24638 |
predicted gene, 24638 |
11644 |
0.17 |
chr8_122751278_122751680 | 19.84 |
C230057M02Rik |
RIKEN cDNA C230057M02 gene |
846 |
0.44 |
chr3_108401377_108402718 | 19.70 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
542 |
0.59 |
chr11_6599159_6600158 | 19.63 |
Nacad |
NAC alpha domain containing |
266 |
0.81 |
chr7_43489442_43490064 | 19.40 |
Iglon5 |
IgLON family member 5 |
322 |
0.72 |
chr2_178142310_178142985 | 19.39 |
Phactr3 |
phosphatase and actin regulator 3 |
714 |
0.75 |
chr4_81727093_81727463 | 19.39 |
Gm11412 |
predicted gene 11412 |
15868 |
0.23 |
chr5_71095688_71096242 | 19.27 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
116 |
0.98 |
chr3_55242068_55243398 | 19.25 |
Dclk1 |
doublecortin-like kinase 1 |
207 |
0.94 |
chr3_8510380_8510590 | 19.20 |
Stmn2 |
stathmin-like 2 |
899 |
0.63 |
chr14_55053693_55054126 | 19.14 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
38 |
0.92 |
chr6_127079842_127080169 | 19.06 |
Fgf23 |
fibroblast growth factor 23 |
7103 |
0.13 |
chr19_6976181_6976733 | 18.91 |
Ppp1r14b |
protein phosphatase 1, regulatory inhibitor subunit 14B |
8 |
0.48 |
chr2_127521161_127522051 | 18.89 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr6_113856666_113857208 | 18.87 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
34433 |
0.12 |
chr4_40948174_40948980 | 18.76 |
Chmp5 |
charged multivesicular body protein 5 |
170 |
0.63 |
chr2_168106742_168107351 | 18.75 |
AL831766.1 |
breast carcinoma amplified sequence 4 (BCAS4) pseudogene |
7831 |
0.14 |
chrX_143902692_143902843 | 18.75 |
Dcx |
doublecortin |
30283 |
0.2 |
chr17_55985980_55986972 | 18.50 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
33 |
0.94 |
chrX_143518921_143519348 | 18.46 |
Pak3 |
p21 (RAC1) activated kinase 3 |
436 |
0.9 |
chr1_120115905_120116482 | 18.41 |
Dbi |
diazepam binding inhibitor |
3945 |
0.21 |
chr7_27164811_27165702 | 18.40 |
Egln2 |
egl-9 family hypoxia-inducible factor 2 |
1026 |
0.26 |
chr11_88588635_88589214 | 18.35 |
Msi2 |
musashi RNA-binding protein 2 |
1223 |
0.57 |
chr13_15759168_15760299 | 18.22 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr4_81727500_81727721 | 18.22 |
Gm11412 |
predicted gene 11412 |
15536 |
0.24 |
chr19_10188295_10188461 | 18.20 |
Mir6993 |
microRNA 6993 |
2997 |
0.13 |
chr16_25016242_25016817 | 18.18 |
A230028O05Rik |
RIKEN cDNA A230028O05 gene |
43110 |
0.19 |
chr9_45433800_45433951 | 18.18 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
2145 |
0.22 |
chr6_91839426_91839831 | 18.11 |
Grip2 |
glutamate receptor interacting protein 2 |
12378 |
0.15 |
chr12_33035669_33036432 | 18.00 |
Cdhr3 |
cadherin-related family member 3 |
16936 |
0.14 |
chr5_111935456_111935676 | 17.92 |
Gm42488 |
predicted gene 42488 |
8669 |
0.27 |
chr9_94611004_94611174 | 17.90 |
Gm39404 |
predicted gene, 39404 |
18893 |
0.17 |
chr3_88225100_88225251 | 17.85 |
Gm3764 |
predicted gene 3764 |
758 |
0.4 |
chr13_84061812_84061979 | 17.83 |
Gm17750 |
predicted gene, 17750 |
2877 |
0.3 |
chr1_167022852_167023009 | 17.81 |
Fam78b |
family with sequence similarity 78, member B |
21341 |
0.18 |
chrX_43429975_43430537 | 17.78 |
Tenm1 |
teneurin transmembrane protein 1 |
1130 |
0.54 |
chr3_88207026_88207397 | 17.75 |
Gm3764 |
predicted gene 3764 |
101 |
0.91 |
chr2_62807459_62807865 | 17.72 |
Gm13569 |
predicted gene 13569 |
1525 |
0.44 |
chr9_26733143_26733768 | 17.69 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
273 |
0.88 |
chr2_26594675_26595827 | 17.69 |
Egfl7 |
EGF-like domain 7 |
3104 |
0.11 |
chr13_83749857_83750036 | 17.68 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr7_79499656_79500079 | 17.68 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chr5_68149972_68150304 | 17.68 |
Gm43025 |
predicted gene 43025 |
65764 |
0.11 |
chr7_57508956_57510254 | 17.61 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
234 |
0.95 |
chr12_29871996_29872873 | 17.58 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr10_19318275_19318532 | 17.54 |
Gm33056 |
predicted gene, 33056 |
27414 |
0.17 |
chr10_121309994_121311399 | 17.52 |
Tbc1d30 |
TBC1 domain family, member 30 |
493 |
0.76 |
chr16_8540589_8540924 | 17.45 |
Abat |
4-aminobutyrate aminotransferase |
27271 |
0.14 |
chr4_141053276_141054195 | 17.44 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
13 |
0.96 |
chr19_41693820_41694136 | 17.41 |
Slit1 |
slit guidance ligand 1 |
49508 |
0.13 |
chr4_22301616_22301795 | 17.32 |
Gm11882 |
predicted gene 11882 |
25872 |
0.19 |
chr17_67071357_67071526 | 17.32 |
Ptprm |
protein tyrosine phosphatase, receptor type, M |
23456 |
0.2 |
chr12_29884527_29884691 | 17.31 |
Myt1l |
myelin transcription factor 1-like |
10505 |
0.26 |
chr3_55448016_55448187 | 17.29 |
Dclk1 |
doublecortin-like kinase 1 |
2872 |
0.22 |
chr7_79572141_79572757 | 17.26 |
Gm45168 |
predicted gene 45168 |
6619 |
0.1 |
chr12_51117995_51118377 | 17.15 |
Gm7172 |
predicted gene 7172 |
16516 |
0.22 |
chr9_103504895_103505451 | 17.12 |
Tmem108 |
transmembrane protein 108 |
11562 |
0.11 |
chr8_4679817_4680161 | 17.09 |
Gm6410 |
predicted gene 6410 |
1527 |
0.23 |
chrX_135210164_135210824 | 17.04 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
193 |
0.92 |
chr9_50064901_50065078 | 16.96 |
Gm47543 |
predicted gene, 47543 |
110111 |
0.06 |
chr2_33355615_33355975 | 16.88 |
Gm25998 |
predicted gene, 25998 |
7251 |
0.17 |
chr10_106469332_106470360 | 16.84 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr11_112501711_112502406 | 16.79 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr14_49294201_49294352 | 16.79 |
Slc35f4 |
solute carrier family 35, member F4 |
4997 |
0.19 |
chr11_52447248_52447521 | 16.72 |
Gm12209 |
predicted gene 12209 |
31719 |
0.13 |
chr10_80145825_80146996 | 16.71 |
Midn |
midnolin |
1862 |
0.15 |
chr8_12915219_12915955 | 16.66 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr17_9879654_9879852 | 16.65 |
Gm49808 |
predicted gene, 49808 |
15334 |
0.19 |
chr3_40949219_40949942 | 16.63 |
Larp1b |
La ribonucleoprotein domain family, member 1B |
248 |
0.88 |
chr13_92733870_92734066 | 16.58 |
Gm5199 |
predicted gene 5199 |
14606 |
0.19 |
chr7_81454347_81455042 | 16.43 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
19 |
0.95 |
chr7_79536149_79536360 | 16.34 |
Gm35040 |
predicted gene, 35040 |
211 |
0.87 |
chr3_144124558_144124728 | 16.23 |
Gm34078 |
predicted gene, 34078 |
11111 |
0.23 |
chr10_81364518_81366962 | 16.18 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr13_83720847_83721021 | 16.18 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
447 |
0.75 |
chrX_71050224_71051202 | 16.15 |
Mamld1 |
mastermind-like domain containing 1 |
457 |
0.87 |
chr3_59005933_59006738 | 16.14 |
Med12l |
mediator complex subunit 12-like |
152 |
0.52 |
chr3_8510073_8510309 | 16.14 |
Stmn2 |
stathmin-like 2 |
605 |
0.77 |
chr2_165288310_165288938 | 16.14 |
Slc35c2 |
solute carrier family 35, member C2 |
755 |
0.58 |
chr10_86491659_86492093 | 16.13 |
Syn3 |
synapsin III |
21 |
0.96 |
chr4_134496569_134497650 | 16.11 |
Paqr7 |
progestin and adipoQ receptor family member VII |
68 |
0.95 |
chr3_105590400_105590551 | 16.10 |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
78530 |
0.07 |
chr7_144449676_144450010 | 16.09 |
Cttn |
cortactin |
69 |
0.97 |
chr1_42687059_42687229 | 16.09 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
5949 |
0.15 |
chr15_44177298_44177482 | 16.07 |
Trhr |
thyrotropin releasing hormone receptor |
18745 |
0.25 |
chr17_9905619_9905814 | 16.00 |
Gm34799 |
predicted gene, 34799 |
24051 |
0.17 |
chr11_118792990_118793180 | 16.00 |
Gm11750 |
predicted gene 11750 |
1713 |
0.38 |
chr6_114182505_114182666 | 15.99 |
Gm8132 |
predicted gene 8132 |
13062 |
0.21 |
chr5_24623512_24623989 | 15.99 |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
614 |
0.58 |
chr2_172345010_172346316 | 15.96 |
Fam210b |
family with sequence similarity 210, member B |
98 |
0.95 |
chr10_5922231_5922649 | 15.96 |
Rgs17 |
regulator of G-protein signaling 17 |
40 |
0.99 |
chr9_56868158_56868636 | 15.94 |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
3364 |
0.16 |
chr6_82939285_82939948 | 15.83 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
71 |
0.94 |
chr18_74956688_74957137 | 15.81 |
Lipg |
lipase, endothelial |
4350 |
0.11 |
chr15_102733338_102733529 | 15.81 |
Calcoco1 |
calcium binding and coiled coil domain 1 |
11255 |
0.14 |
chr13_34133643_34133908 | 15.80 |
Gm36500 |
predicted gene, 36500 |
85 |
0.94 |
chr14_13651648_13651848 | 15.79 |
Sntn |
sentan, cilia apical structure protein |
19128 |
0.24 |
chr12_72236963_72237171 | 15.78 |
Rtn1 |
reticulon 1 |
343 |
0.9 |
chr5_103789859_103790167 | 15.75 |
Aff1 |
AF4/FMR2 family, member 1 |
5654 |
0.23 |
chr2_24428384_24428703 | 15.75 |
Pax8 |
paired box 8 |
5461 |
0.15 |
chr8_108510737_108511320 | 15.73 |
Gm39244 |
predicted gene, 39244 |
25919 |
0.23 |
chr9_98525136_98525555 | 15.72 |
Gm37113 |
predicted gene, 37113 |
31377 |
0.11 |
chr14_27167240_27167560 | 15.71 |
Gm7591 |
predicted gene 7591 |
42997 |
0.14 |
chr8_71374903_71376449 | 15.71 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
114 |
0.92 |
chr6_40024235_40024578 | 15.53 |
Gm37995 |
predicted gene, 37995 |
2488 |
0.33 |
chr11_97449609_97450728 | 15.52 |
Arhgap23 |
Rho GTPase activating protein 23 |
8 |
0.97 |
chr13_48966851_48968700 | 15.47 |
Fam120a |
family with sequence similarity 120, member A |
242 |
0.95 |
chr4_154960398_154960784 | 15.47 |
Hes5 |
hes family bHLH transcription factor 5 |
332 |
0.74 |
chr14_3208167_3209194 | 15.42 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr5_33689415_33689612 | 15.39 |
Gm42965 |
predicted gene 42965 |
6539 |
0.11 |
chr12_33341296_33341797 | 15.39 |
Atxn7l1 |
ataxin 7-like 1 |
3759 |
0.23 |
chr6_145934272_145934704 | 15.39 |
Sspn |
sarcospan |
366 |
0.85 |
chr7_25676228_25676843 | 15.38 |
Tmem91 |
transmembrane protein 91 |
1369 |
0.23 |
chr1_173367824_173368059 | 15.36 |
Cadm3 |
cell adhesion molecule 3 |
246 |
0.91 |
chr1_89302339_89302583 | 15.33 |
Gm5259 |
predicted gene 5259 |
45480 |
0.15 |
chr16_41729236_41729556 | 15.32 |
Lsamp |
limbic system-associated membrane protein |
195977 |
0.03 |
chr1_74855060_74855505 | 15.27 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
348 |
0.78 |
chr15_86419577_86420037 | 15.24 |
A930001M01Rik |
RIKEN cDNA A930001M01 gene |
55288 |
0.15 |
chr13_72265859_72266010 | 15.24 |
Gm4052 |
predicted gene 4052 |
84287 |
0.09 |
chr15_25842982_25843686 | 15.23 |
Retreg1 |
reticulophagy regulator 1 |
154 |
0.95 |
chr1_74284190_74285456 | 15.22 |
Aamp |
angio-associated migratory protein |
85 |
0.51 |
chr14_105851365_105851748 | 15.18 |
Gm48970 |
predicted gene, 48970 |
10945 |
0.21 |
chr11_88471971_88472344 | 15.17 |
Gm11510 |
predicted gene 11510 |
38643 |
0.16 |
chr11_66222237_66222458 | 15.15 |
Dnah9 |
dynein, axonemal, heavy chain 9 |
53796 |
0.15 |
chr4_120188706_120189284 | 15.15 |
Edn2 |
endothelin 2 |
27789 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.1 | 51.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
15.3 | 46.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
14.8 | 44.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
12.3 | 49.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
11.3 | 33.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
10.2 | 30.7 | GO:0021586 | pons maturation(GO:0021586) |
10.0 | 79.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
9.2 | 27.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
9.2 | 27.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
8.8 | 35.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
8.8 | 26.3 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
8.4 | 33.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
8.3 | 24.8 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
8.3 | 33.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
8.1 | 48.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
8.0 | 32.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
8.0 | 24.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
8.0 | 23.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
7.9 | 23.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
7.6 | 30.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
7.5 | 29.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
7.4 | 7.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
7.4 | 37.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
7.3 | 21.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
7.2 | 50.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
7.1 | 28.5 | GO:0046959 | habituation(GO:0046959) |
7.1 | 7.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
7.0 | 55.6 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
6.9 | 6.9 | GO:0021550 | medulla oblongata development(GO:0021550) |
6.7 | 20.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
6.6 | 138.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
6.5 | 26.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
6.5 | 12.9 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
6.4 | 64.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
6.4 | 44.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
6.4 | 25.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
6.2 | 31.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
6.2 | 6.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
5.9 | 29.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
5.9 | 11.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
5.8 | 17.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
5.8 | 23.0 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
5.6 | 5.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
5.5 | 27.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
5.5 | 76.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
5.5 | 32.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
5.3 | 21.3 | GO:0090427 | activation of meiosis(GO:0090427) |
5.3 | 37.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.2 | 10.5 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
5.2 | 15.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
5.2 | 10.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
5.1 | 15.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.1 | 20.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.1 | 15.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
5.1 | 15.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
5.0 | 15.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
5.0 | 15.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
5.0 | 15.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
5.0 | 9.9 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
4.9 | 68.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
4.9 | 49.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
4.9 | 14.6 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.8 | 4.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.8 | 14.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
4.8 | 9.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
4.8 | 14.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
4.8 | 14.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
4.7 | 32.6 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
4.6 | 23.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
4.6 | 13.7 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
4.6 | 18.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
4.5 | 40.8 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
4.5 | 9.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
4.5 | 22.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.5 | 17.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
4.5 | 35.6 | GO:0071625 | vocalization behavior(GO:0071625) |
4.5 | 8.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
4.4 | 8.9 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
4.4 | 4.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
4.4 | 34.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
4.3 | 8.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
4.3 | 17.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.3 | 17.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
4.3 | 12.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
4.3 | 51.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
4.2 | 21.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
4.1 | 29.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
4.1 | 32.9 | GO:0001964 | startle response(GO:0001964) |
4.1 | 12.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
4.0 | 12.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
4.0 | 28.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
4.0 | 12.0 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
3.9 | 19.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
3.9 | 23.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
3.9 | 3.9 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
3.8 | 11.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.8 | 15.2 | GO:0022038 | corpus callosum development(GO:0022038) |
3.8 | 11.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.8 | 22.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.8 | 7.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.7 | 26.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
3.7 | 11.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.7 | 3.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
3.7 | 22.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.7 | 7.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
3.6 | 29.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
3.6 | 69.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
3.6 | 3.6 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
3.6 | 10.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
3.6 | 7.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
3.6 | 28.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
3.6 | 17.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
3.6 | 39.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
3.6 | 21.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
3.5 | 10.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
3.5 | 14.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
3.5 | 3.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.5 | 10.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
3.5 | 10.4 | GO:0001927 | exocyst assembly(GO:0001927) |
3.4 | 161.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.4 | 17.1 | GO:0036233 | glycine import(GO:0036233) |
3.4 | 10.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
3.4 | 6.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
3.4 | 10.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
3.4 | 13.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.3 | 10.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.3 | 259.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
3.3 | 3.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
3.3 | 46.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
3.3 | 16.5 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
3.3 | 3.3 | GO:0021557 | oculomotor nerve development(GO:0021557) |
3.3 | 13.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.3 | 6.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
3.3 | 3.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.3 | 9.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.2 | 3.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) regulation of synaptic vesicle clustering(GO:2000807) |
3.2 | 9.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
3.2 | 12.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
3.2 | 19.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.2 | 9.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.2 | 12.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.2 | 9.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.1 | 18.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
3.1 | 21.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
3.1 | 9.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
3.1 | 6.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
3.0 | 9.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.0 | 9.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
3.0 | 9.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.0 | 18.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
3.0 | 9.0 | GO:0030070 | insulin processing(GO:0030070) |
3.0 | 6.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
3.0 | 8.9 | GO:0021764 | amygdala development(GO:0021764) |
3.0 | 11.9 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
3.0 | 17.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
3.0 | 8.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
3.0 | 8.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
2.9 | 14.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.9 | 26.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
2.9 | 8.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.9 | 8.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.9 | 35.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.9 | 5.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.9 | 20.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.9 | 23.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.9 | 8.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
2.8 | 2.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.8 | 8.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.8 | 8.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.8 | 19.7 | GO:0006108 | malate metabolic process(GO:0006108) |
2.8 | 2.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.8 | 11.2 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
2.8 | 19.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.8 | 8.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.8 | 13.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
2.8 | 11.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.8 | 68.8 | GO:0019228 | neuronal action potential(GO:0019228) |
2.7 | 8.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.7 | 19.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.7 | 8.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
2.7 | 8.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.7 | 8.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.7 | 8.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.7 | 2.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
2.7 | 10.7 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
2.7 | 2.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
2.7 | 13.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.7 | 10.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.6 | 2.6 | GO:1903416 | response to glycoside(GO:1903416) |
2.6 | 15.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.6 | 2.6 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
2.6 | 36.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
2.6 | 5.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
2.6 | 5.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
2.6 | 7.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.6 | 5.2 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.6 | 7.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.6 | 5.1 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
2.6 | 15.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
2.6 | 12.8 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
2.6 | 43.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.6 | 2.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.5 | 7.6 | GO:0014029 | neural crest formation(GO:0014029) |
2.5 | 22.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.5 | 15.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.5 | 2.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.5 | 7.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.5 | 12.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.5 | 5.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
2.5 | 12.4 | GO:0033762 | response to glucagon(GO:0033762) |
2.5 | 7.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.4 | 7.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.4 | 23.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
2.4 | 4.7 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.4 | 9.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
2.4 | 37.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
2.3 | 16.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.3 | 4.7 | GO:0051665 | membrane raft localization(GO:0051665) |
2.3 | 14.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.3 | 4.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.3 | 9.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.3 | 4.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.3 | 4.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.3 | 13.7 | GO:0050957 | equilibrioception(GO:0050957) |
2.3 | 2.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.3 | 6.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
2.3 | 13.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.2 | 6.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.2 | 8.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.2 | 4.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
2.2 | 4.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.2 | 6.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
2.2 | 4.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
2.2 | 2.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
2.2 | 4.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.2 | 13.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
2.2 | 6.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.1 | 6.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.1 | 4.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
2.1 | 6.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
2.1 | 4.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.1 | 6.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.1 | 2.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
2.1 | 4.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.1 | 2.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
2.1 | 4.1 | GO:0035973 | aggrephagy(GO:0035973) |
2.0 | 8.2 | GO:0021854 | hypothalamus development(GO:0021854) |
2.0 | 12.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.0 | 10.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
2.0 | 30.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
2.0 | 8.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
2.0 | 16.2 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
2.0 | 14.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
2.0 | 4.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.0 | 4.0 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
2.0 | 6.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.0 | 6.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
2.0 | 15.9 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
2.0 | 4.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.0 | 5.9 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
2.0 | 2.0 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.9 | 3.9 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.9 | 9.7 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.9 | 5.8 | GO:0019086 | late viral transcription(GO:0019086) |
1.9 | 5.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.9 | 5.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.9 | 11.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.9 | 7.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.9 | 5.7 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
1.9 | 3.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.9 | 1.9 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
1.9 | 3.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.9 | 3.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.9 | 5.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.8 | 5.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.8 | 14.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.8 | 12.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.8 | 67.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.8 | 7.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.8 | 1.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.8 | 18.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.8 | 5.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.8 | 1.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.8 | 3.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.8 | 1.8 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.8 | 10.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.8 | 3.5 | GO:0099612 | protein localization to axon(GO:0099612) |
1.8 | 10.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.7 | 5.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.7 | 8.7 | GO:0033227 | dsRNA transport(GO:0033227) |
1.7 | 7.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.7 | 5.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.7 | 6.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
1.7 | 5.1 | GO:0060437 | lung growth(GO:0060437) |
1.7 | 1.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.7 | 3.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.7 | 3.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.7 | 1.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.7 | 11.8 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
1.7 | 5.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
1.7 | 1.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.7 | 6.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.7 | 5.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.7 | 3.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.6 | 6.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.6 | 23.0 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.6 | 9.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.6 | 4.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.6 | 4.9 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
1.6 | 8.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.6 | 4.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 6.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.6 | 4.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
1.6 | 8.0 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.6 | 6.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.6 | 4.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.6 | 1.6 | GO:0001840 | neural plate development(GO:0001840) |
1.6 | 4.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.6 | 4.8 | GO:0060005 | vestibular reflex(GO:0060005) |
1.6 | 15.8 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.6 | 7.9 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
1.6 | 4.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.6 | 4.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.6 | 6.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
1.6 | 4.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.6 | 4.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.5 | 10.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.5 | 167.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.5 | 3.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.5 | 4.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.5 | 6.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.5 | 1.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.5 | 1.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.5 | 6.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.5 | 41.0 | GO:0034605 | cellular response to heat(GO:0034605) |
1.5 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.5 | 1.5 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.5 | 6.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.5 | 7.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 7.5 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.5 | 12.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.5 | 4.5 | GO:0015824 | proline transport(GO:0015824) |
1.5 | 6.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.5 | 1.5 | GO:2000848 | positive regulation of cortisol secretion(GO:0051464) positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of glucocorticoid secretion(GO:2000851) |
1.5 | 4.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.5 | 3.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.5 | 4.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.5 | 4.4 | GO:0015888 | thiamine transport(GO:0015888) |
1.5 | 4.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.5 | 1.5 | GO:0048382 | mesendoderm development(GO:0048382) |
1.5 | 1.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.5 | 2.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.5 | 17.5 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
1.5 | 4.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.5 | 1.5 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.4 | 53.2 | GO:0046847 | filopodium assembly(GO:0046847) |
1.4 | 5.8 | GO:0070986 | left/right axis specification(GO:0070986) |
1.4 | 2.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.4 | 2.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.4 | 11.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.4 | 7.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.4 | 2.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.4 | 2.8 | GO:0014028 | notochord formation(GO:0014028) |
1.4 | 4.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.4 | 2.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.4 | 5.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.4 | 8.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.4 | 4.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.4 | 5.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.4 | 5.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.4 | 7.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.4 | 5.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.4 | 5.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.4 | 6.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.4 | 6.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.4 | 4.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.3 | 4.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.3 | 2.7 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of mesodermal cell fate specification(GO:0042662) |
1.3 | 4.0 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 4.0 | GO:0009642 | response to light intensity(GO:0009642) |
1.3 | 4.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.3 | 10.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.3 | 5.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 3.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.3 | 3.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.3 | 23.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
1.3 | 2.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.3 | 1.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.3 | 2.6 | GO:0015755 | fructose transport(GO:0015755) |
1.3 | 3.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.3 | 2.6 | GO:0090135 | actin filament branching(GO:0090135) |
1.3 | 2.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 15.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.3 | 3.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
1.3 | 6.4 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) cilium movement involved in cell motility(GO:0060294) |
1.3 | 7.7 | GO:0010842 | retina layer formation(GO:0010842) |
1.3 | 1.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.3 | 6.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.3 | 1.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.3 | 19.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
1.3 | 3.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.3 | 5.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.3 | 2.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 3.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.3 | 3.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.3 | 3.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.3 | 8.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
1.3 | 3.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.3 | 3.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.3 | 3.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.3 | 2.5 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.3 | 5.0 | GO:0007614 | short-term memory(GO:0007614) |
1.2 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
1.2 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.2 | 1.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.2 | 13.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
1.2 | 6.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
1.2 | 12.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.2 | 12.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.2 | 2.4 | GO:0006562 | proline catabolic process(GO:0006562) |
1.2 | 1.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.2 | 2.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.2 | 3.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.2 | 1.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.2 | 6.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.2 | 13.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.2 | 1.2 | GO:0015819 | lysine transport(GO:0015819) |
1.2 | 2.4 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.2 | 2.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.2 | 2.4 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.2 | 9.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.2 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
1.2 | 19.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.2 | 1.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.2 | 8.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.2 | 33.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.2 | 3.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.2 | 1.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.2 | 4.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 10.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
1.2 | 3.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.2 | 3.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.1 | 2.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.1 | 2.3 | GO:0060013 | righting reflex(GO:0060013) |
1.1 | 11.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.1 | 4.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.1 | 5.7 | GO:0001975 | response to amphetamine(GO:0001975) |
1.1 | 3.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
1.1 | 1.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.1 | 9.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.1 | 3.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.1 | 5.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.1 | 3.3 | GO:0060618 | nipple development(GO:0060618) |
1.1 | 4.4 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
1.1 | 3.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.1 | 7.7 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.1 | 4.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 3.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.1 | 1.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.1 | 4.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.1 | 3.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.1 | 7.7 | GO:0036065 | fucosylation(GO:0036065) |
1.1 | 1.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.1 | 5.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 7.6 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
1.1 | 9.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.1 | 5.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.1 | 4.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.1 | 24.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.1 | 2.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.1 | 2.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.1 | 3.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.1 | 2.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.1 | 5.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.1 | 23.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
1.1 | 4.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.1 | 5.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.1 | 2.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.1 | 2.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 3.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.1 | 3.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.1 | 2.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.1 | 3.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.1 | 3.2 | GO:0060179 | male mating behavior(GO:0060179) |
1.0 | 3.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 2.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.0 | 2.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.0 | 12.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.0 | 9.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.0 | 4.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.0 | 1.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
1.0 | 2.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.0 | 4.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.0 | 2.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.0 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.0 | 1.0 | GO:0098901 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) regulation of cardiac muscle cell action potential(GO:0098901) |
1.0 | 60.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
1.0 | 37.2 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
1.0 | 1.0 | GO:0072017 | distal tubule development(GO:0072017) |
1.0 | 8.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.0 | 1.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
1.0 | 3.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.0 | 20.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
1.0 | 4.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.0 | 2.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.0 | 2.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.0 | 23.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.0 | 3.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 3.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.0 | 1.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.0 | 3.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 3.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.0 | 3.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.0 | 3.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.0 | 1.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 1.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
1.0 | 5.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.0 | 2.9 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.0 | 1.9 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.0 | 10.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
1.0 | 1.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.9 | 2.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.9 | 2.8 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.9 | 1.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.9 | 2.8 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.9 | 6.6 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.9 | 1.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.9 | 7.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.9 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.9 | 6.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.9 | 4.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 2.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.9 | 1.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.9 | 3.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.9 | 1.8 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.9 | 1.8 | GO:0032252 | secretory granule localization(GO:0032252) |
0.9 | 10.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.9 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 5.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.9 | 7.2 | GO:0060180 | female mating behavior(GO:0060180) |
0.9 | 13.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.9 | 2.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 3.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.9 | 2.7 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.9 | 1.8 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.9 | 2.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 4.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.9 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 2.6 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.9 | 1.7 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.9 | 3.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.9 | 2.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 8.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.9 | 4.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.9 | 1.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 0.8 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.8 | 5.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 3.4 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.8 | 3.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 2.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.8 | 2.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.8 | 0.8 | GO:0070368 | regulation of hepatocyte differentiation(GO:0070366) positive regulation of hepatocyte differentiation(GO:0070368) |
0.8 | 13.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.8 | 4.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.8 | 1.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.8 | 8.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.8 | 2.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.8 | 0.8 | GO:0002339 | B cell selection(GO:0002339) |
0.8 | 15.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 3.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.8 | 4.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 1.6 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.8 | 5.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 8.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 2.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.8 | 9.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.8 | 1.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 3.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 1.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.8 | 7.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.8 | 2.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.8 | 0.8 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.8 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 1.5 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.8 | 3.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.8 | 0.8 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.8 | 42.7 | GO:0007626 | locomotory behavior(GO:0007626) |
0.8 | 5.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.8 | 0.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.8 | 23.3 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.7 | 3.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 1.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 3.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.7 | 0.7 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.7 | 1.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.7 | 0.7 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.7 | 1.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.7 | 3.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 5.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.7 | 0.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 1.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.7 | 5.0 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.7 | 6.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.7 | 0.7 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.7 | 5.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.7 | 1.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.7 | 2.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.7 | 2.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.7 | 2.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.7 | 1.4 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 2.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 2.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 2.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.7 | 4.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.7 | 2.8 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 1.4 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.7 | 0.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.7 | 0.7 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.7 | 4.1 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 4.8 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.7 | 2.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.7 | 14.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.7 | 4.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.7 | 1.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.7 | 2.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 14.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.7 | 2.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.7 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.7 | 4.0 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.7 | 1.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 6.6 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.6 | 5.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 1.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.6 | 3.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 2.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.6 | 1.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 2.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.6 | 4.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.6 | 2.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.6 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.6 | 3.7 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.6 | 3.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.6 | 1.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 1.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.6 | 1.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.6 | 1.8 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.6 | 1.8 | GO:0042048 | olfactory behavior(GO:0042048) |
0.6 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.8 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 1.7 | GO:0001895 | retina homeostasis(GO:0001895) |
0.6 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 0.6 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.6 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.6 | 1.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 1.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.6 | 1.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.6 | 6.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.6 | 1.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 3.8 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 2.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.5 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 0.5 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.5 | 1.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.5 | 5.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 3.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.5 | 3.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 0.5 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.5 | 0.5 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) positive regulation of transcription by glucose(GO:0046016) |
0.5 | 2.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 1.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.5 | 1.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.5 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.5 | 0.5 | GO:0035637 | multicellular organismal signaling(GO:0035637) |
0.5 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 1.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.5 | 5.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.5 | 1.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.5 | 2.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 4.5 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.5 | 0.5 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.5 | 1.5 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 3.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 1.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 0.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.5 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 1.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 1.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 3.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.5 | 1.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 3.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 0.9 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.5 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 0.5 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.5 | 2.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 3.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 8.6 | GO:0006813 | potassium ion transport(GO:0006813) |
0.5 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 9.4 | GO:0048278 | vesicle docking(GO:0048278) |
0.4 | 1.3 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 2.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.4 | 1.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 4.3 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 2.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 1.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 1.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 6.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 4.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 1.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.4 | 2.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.4 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 1.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 0.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 1.2 | GO:0003157 | endocardium development(GO:0003157) |
0.4 | 0.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 1.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 0.4 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.4 | 3.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 1.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 2.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 3.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.4 | 1.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 2.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 0.4 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.4 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.4 | 0.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.4 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 0.7 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.4 | 0.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.4 | 1.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 0.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.4 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 0.4 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.4 | 1.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 1.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 3.0 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 3.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 5.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 2.3 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.3 | 2.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 1.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 2.6 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.3 | 1.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 2.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.6 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 1.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 0.6 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.3 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 0.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 4.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 0.9 | GO:0015846 | polyamine transport(GO:0015846) |
0.3 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 2.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 2.6 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 4.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 1.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 4.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.8 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 3.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 1.0 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.2 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 11.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.4 | GO:1904504 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 5.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.5 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.2 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 1.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 3.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.7 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 2.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.5 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 2.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.3 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.2 | 1.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.6 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.5 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.7 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 1.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 1.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 2.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 3.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.1 | 3.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.2 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.0 | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.9 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 32.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
9.4 | 28.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
7.6 | 76.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
7.5 | 45.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
7.0 | 21.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
7.0 | 48.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
6.6 | 33.0 | GO:0097433 | dense body(GO:0097433) |
6.6 | 19.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
6.4 | 25.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
6.2 | 18.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
6.2 | 166.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
6.1 | 36.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.0 | 6.0 | GO:0005883 | neurofilament(GO:0005883) |
6.0 | 30.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
6.0 | 71.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
5.9 | 17.6 | GO:0072534 | perineuronal net(GO:0072534) |
5.7 | 17.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
5.2 | 181.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
5.1 | 10.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
4.9 | 4.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.7 | 47.4 | GO:0030673 | axolemma(GO:0030673) |
4.7 | 14.1 | GO:0097441 | basilar dendrite(GO:0097441) |
4.7 | 18.7 | GO:0033010 | paranodal junction(GO:0033010) |
4.5 | 72.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
4.5 | 4.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
4.4 | 8.8 | GO:0033268 | node of Ranvier(GO:0033268) |
4.4 | 123.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
4.3 | 8.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.1 | 37.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
4.0 | 48.5 | GO:0071564 | npBAF complex(GO:0071564) |
3.9 | 46.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
3.9 | 11.7 | GO:0043511 | inhibin complex(GO:0043511) |
3.9 | 11.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.9 | 27.0 | GO:0032584 | growth cone membrane(GO:0032584) |
3.7 | 14.9 | GO:0043194 | axon initial segment(GO:0043194) |
3.7 | 40.3 | GO:0042555 | MCM complex(GO:0042555) |
3.7 | 11.0 | GO:0097427 | microtubule bundle(GO:0097427) |
3.6 | 86.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
3.5 | 87.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.3 | 36.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
3.3 | 13.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
3.3 | 9.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.3 | 3.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.2 | 16.2 | GO:0043083 | synaptic cleft(GO:0043083) |
3.2 | 187.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
3.2 | 48.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
3.1 | 12.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
3.0 | 9.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.0 | 12.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.9 | 8.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
2.8 | 16.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.7 | 370.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
2.6 | 28.8 | GO:0097440 | apical dendrite(GO:0097440) |
2.6 | 5.2 | GO:0097413 | Lewy body(GO:0097413) |
2.6 | 10.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.5 | 20.3 | GO:0032590 | dendrite membrane(GO:0032590) |
2.5 | 42.1 | GO:0044295 | axonal growth cone(GO:0044295) |
2.4 | 243.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.3 | 4.7 | GO:0043219 | lateral loop(GO:0043219) |
2.2 | 2.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.2 | 10.8 | GO:0070695 | FHF complex(GO:0070695) |
2.2 | 2.2 | GO:0042585 | germinal vesicle(GO:0042585) |
2.1 | 177.0 | GO:0030426 | growth cone(GO:0030426) |
2.1 | 24.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
2.0 | 14.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
2.0 | 6.0 | GO:0036396 | MIS complex(GO:0036396) |
2.0 | 11.9 | GO:0016600 | flotillin complex(GO:0016600) |
2.0 | 7.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.9 | 11.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.9 | 18.9 | GO:0031045 | dense core granule(GO:0031045) |
1.9 | 22.7 | GO:0034704 | calcium channel complex(GO:0034704) |
1.9 | 7.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.8 | 23.9 | GO:0043198 | dendritic shaft(GO:0043198) |
1.8 | 7.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.8 | 12.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.8 | 62.5 | GO:0098794 | postsynapse(GO:0098794) |
1.8 | 14.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.7 | 5.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.7 | 6.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.7 | 3.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.6 | 6.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 4.6 | GO:0048179 | activin receptor complex(GO:0048179) |
1.5 | 7.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.5 | 6.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 8.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.5 | 7.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.4 | 4.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.4 | 2.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.4 | 9.7 | GO:0060076 | excitatory synapse(GO:0060076) |
1.4 | 65.3 | GO:0043195 | terminal bouton(GO:0043195) |
1.4 | 4.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.3 | 289.2 | GO:0045202 | synapse(GO:0045202) |
1.3 | 11.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.3 | 7.8 | GO:0030008 | TRAPP complex(GO:0030008) |
1.3 | 7.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.2 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.2 | 14.7 | GO:0046930 | pore complex(GO:0046930) |
1.2 | 2.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.2 | 3.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.2 | 3.5 | GO:0030427 | site of polarized growth(GO:0030427) |
1.1 | 4.5 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 65.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.1 | 16.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.1 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 4.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 3.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.0 | 3.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.0 | 7.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.0 | 11.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.0 | 28.1 | GO:0005921 | gap junction(GO:0005921) |
1.0 | 5.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.9 | 9.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.9 | 2.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 11.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 0.9 | GO:0005818 | aster(GO:0005818) |
0.9 | 3.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.9 | 2.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.9 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.8 | 2.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.8 | 1.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.8 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.8 | 4.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.8 | 1.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.8 | 3.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.8 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.8 | 1.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 3.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.7 | 3.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 5.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.7 | 5.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.7 | 9.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.7 | 2.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 7.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.7 | 6.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 2.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 34.9 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 5.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 2.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.6 | 1.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 8.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.6 | 3.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 2.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 1.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 1.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 1.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 4.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.5 | 4.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 3.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 3.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 7.0 | GO:0001741 | XY body(GO:0001741) |
0.5 | 4.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.5 | 4.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 3.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.5 | 3.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.5 | 1.4 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 1.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 1.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 0.5 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.5 | 60.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 4.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 8.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.4 | 4.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 1.3 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 15.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.4 | 2.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 2.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 3.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 15.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 21.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.4 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 8.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 17.7 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.3 | 1.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 4.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 3.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.3 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 32.5 | GO:0030424 | axon(GO:0030424) |
0.2 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 2.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 3.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 2.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 43.9 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 5.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.6 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 1.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.5 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 3.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 78.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 72.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
17.1 | 51.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
13.7 | 13.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
13.5 | 54.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
11.3 | 33.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
10.6 | 42.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
10.0 | 40.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
9.6 | 19.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
8.9 | 26.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
8.7 | 26.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
8.5 | 76.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
8.2 | 65.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
7.9 | 31.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
7.7 | 23.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
7.6 | 22.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.6 | 22.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
7.4 | 29.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
7.4 | 22.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
7.2 | 28.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
7.0 | 20.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
6.9 | 20.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
6.7 | 6.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
6.6 | 19.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.4 | 25.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
6.3 | 82.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
6.3 | 44.0 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
6.2 | 37.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
6.1 | 18.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.9 | 35.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
5.8 | 17.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
5.7 | 80.0 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
5.7 | 34.1 | GO:0048495 | Roundabout binding(GO:0048495) |
5.7 | 17.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
5.6 | 72.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
5.6 | 27.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.5 | 5.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
5.4 | 26.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.2 | 10.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
5.1 | 15.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
4.6 | 18.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.4 | 26.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.4 | 4.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.2 | 21.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.2 | 33.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.2 | 21.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.2 | 16.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
4.1 | 12.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
4.0 | 28.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.0 | 40.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
4.0 | 16.0 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
3.9 | 39.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
3.9 | 3.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
3.9 | 11.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.9 | 11.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.8 | 15.4 | GO:0030911 | TPR domain binding(GO:0030911) |
3.8 | 18.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.8 | 15.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.8 | 52.6 | GO:0031402 | sodium ion binding(GO:0031402) |
3.7 | 52.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
3.7 | 14.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
3.6 | 18.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.6 | 67.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.4 | 37.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
3.3 | 43.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
3.3 | 13.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
3.3 | 16.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.2 | 9.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.2 | 12.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
3.2 | 6.4 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
3.2 | 9.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.1 | 9.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
3.1 | 12.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
3.1 | 9.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.1 | 15.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
3.1 | 3.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.0 | 12.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.0 | 91.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.0 | 9.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.0 | 9.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
3.0 | 23.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.9 | 2.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.9 | 5.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.8 | 8.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.8 | 22.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
2.8 | 11.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.8 | 38.8 | GO:0016917 | GABA receptor activity(GO:0016917) |
2.7 | 16.4 | GO:0034711 | inhibin binding(GO:0034711) |
2.7 | 8.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.7 | 19.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.7 | 5.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.7 | 16.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.7 | 10.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.6 | 18.5 | GO:0003680 | AT DNA binding(GO:0003680) |
2.6 | 18.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
2.6 | 7.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.6 | 7.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.6 | 2.6 | GO:0051378 | serotonin binding(GO:0051378) |
2.5 | 20.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
2.5 | 7.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.5 | 2.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.5 | 9.8 | GO:0030955 | potassium ion binding(GO:0030955) |
2.4 | 14.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.4 | 9.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.4 | 16.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.4 | 9.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.4 | 4.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.4 | 9.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.3 | 14.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.3 | 4.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.3 | 13.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.3 | 11.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.2 | 6.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.2 | 6.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
2.2 | 29.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
2.2 | 24.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.2 | 6.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
2.2 | 19.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.2 | 2.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
2.2 | 43.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.2 | 8.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.2 | 13.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.2 | 56.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
2.2 | 4.3 | GO:0050693 | LBD domain binding(GO:0050693) |
2.2 | 15.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.2 | 6.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.1 | 15.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
2.1 | 29.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.1 | 6.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
2.1 | 10.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.0 | 20.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.0 | 22.2 | GO:0005522 | profilin binding(GO:0005522) |
2.0 | 42.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.0 | 4.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.0 | 6.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.0 | 6.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.0 | 10.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.0 | 3.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.9 | 3.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.9 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.9 | 30.0 | GO:0005272 | sodium channel activity(GO:0005272) |
1.9 | 5.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.9 | 46.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.8 | 7.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.8 | 27.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.8 | 5.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.8 | 5.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.8 | 5.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.8 | 5.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.8 | 10.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.8 | 55.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.8 | 7.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.7 | 5.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.7 | 8.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.7 | 1.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.7 | 6.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.7 | 13.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.7 | 5.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.7 | 1.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.7 | 15.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.7 | 8.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.7 | 3.3 | GO:0097016 | L27 domain binding(GO:0097016) |
1.7 | 5.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.7 | 8.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.6 | 4.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.6 | 19.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 4.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 11.3 | GO:0033691 | sialic acid binding(GO:0033691) |
1.6 | 6.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.6 | 1.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.6 | 4.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.6 | 7.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.6 | 4.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.6 | 23.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.5 | 13.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.5 | 9.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.5 | 4.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.5 | 4.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.5 | 6.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.5 | 2.9 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.5 | 1.5 | GO:0002046 | opsin binding(GO:0002046) |
1.4 | 20.2 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.4 | 2.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.4 | 59.1 | GO:0030276 | clathrin binding(GO:0030276) |
1.4 | 9.8 | GO:0030957 | Tat protein binding(GO:0030957) |
1.4 | 5.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.4 | 44.3 | GO:0019894 | kinesin binding(GO:0019894) |
1.4 | 26.1 | GO:0030332 | cyclin binding(GO:0030332) |
1.4 | 5.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.4 | 4.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 6.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.4 | 1.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
1.3 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.3 | 4.0 | GO:0043919 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
1.3 | 1.3 | GO:0032564 | dATP binding(GO:0032564) |
1.3 | 11.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 6.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.3 | 27.4 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.3 | 3.9 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.2 | 7.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.2 | 32.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
1.2 | 3.7 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 33.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.2 | 2.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.2 | 25.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.2 | 6.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.2 | 2.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.2 | 25.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.2 | 12.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.2 | 6.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.2 | 4.8 | GO:0070052 | collagen V binding(GO:0070052) |
1.2 | 3.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 29.8 | GO:0030507 | spectrin binding(GO:0030507) |
1.2 | 3.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.2 | 5.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.2 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.2 | 1.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
1.2 | 3.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.2 | 5.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.2 | 5.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 4.6 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
1.1 | 4.6 | GO:0097001 | ceramide binding(GO:0097001) |
1.1 | 4.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 10.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.1 | 27.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.1 | 2.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 22.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.1 | 5.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.1 | 47.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.1 | 21.3 | GO:0003785 | actin monomer binding(GO:0003785) |
1.1 | 5.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.0 | 7.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.0 | 12.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.0 | 4.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.0 | 5.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.0 | 5.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 9.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.0 | 2.0 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.0 | 4.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 2.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.0 | 32.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.0 | 22.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.0 | 1.9 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 3.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.9 | 3.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.9 | 6.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 20.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.9 | 21.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.9 | 2.7 | GO:0018588 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.9 | 6.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.9 | 4.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.9 | 6.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.9 | 18.6 | GO:0005537 | mannose binding(GO:0005537) |
0.9 | 2.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.9 | 14.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.9 | 2.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 2.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.9 | 12.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 2.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 6.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 45.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.8 | 10.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.8 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.8 | 2.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.8 | 3.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 20.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 2.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 22.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.8 | 4.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 10.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 0.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 8.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.8 | 2.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 4.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.8 | 2.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 2.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 3.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 23.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.7 | 4.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 2.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 2.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.7 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.7 | 2.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 6.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.7 | 3.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.7 | 3.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.7 | 7.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.7 | 1.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.7 | 6.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 16.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.7 | 8.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 8.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 23.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 6.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 1.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 10.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.7 | 3.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 3.3 | GO:0034841 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.7 | 16.5 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.7 | 2.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 3.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 2.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 2.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 9.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.6 | 3.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 7.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 6.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 1.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 2.4 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 4.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 10.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.6 | 30.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.6 | 7.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.6 | 2.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 1.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.6 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.6 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 2.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.5 | 3.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 2.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 4.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 1.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 6.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 13.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 6.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.5 | 2.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 6.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.5 | 1.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 1.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 2.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 3.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 2.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 6.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.4 | 3.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 3.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 4.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 2.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 33.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 1.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 1.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 1.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 0.4 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.4 | 8.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.4 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.4 | 4.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 1.6 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.4 | 1.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.4 | 3.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 1.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 2.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 3.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 0.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 2.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 2.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.3 | 4.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 1.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 1.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 2.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 0.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 1.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 3.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.2 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 5.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.9 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.2 | 2.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.6 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 74.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 5.1 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 3.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 2.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.2 | GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 4.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 2.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 1.9 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 13.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 146.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.0 | 27.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.7 | 2.7 | ST ADRENERGIC | Adrenergic Pathway |
2.2 | 2.2 | PID IGF1 PATHWAY | IGF1 pathway |
2.1 | 41.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.0 | 13.7 | PID ALK2 PATHWAY | ALK2 signaling events |
1.9 | 27.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.9 | 26.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.8 | 51.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.8 | 3.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.5 | 12.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.2 | 44.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
1.0 | 19.7 | PID SHP2 PATHWAY | SHP2 signaling |
1.0 | 8.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 10.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.0 | 23.7 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 20.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.9 | 15.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.9 | 7.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.9 | 3.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.9 | 9.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 26.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 8.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.8 | 5.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 5.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.8 | 12.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 22.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 21.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 15.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 22.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.5 | 10.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 1.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 14.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 12.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 12.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 7.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 4.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 3.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 3.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 7.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 8.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 14.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.6 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 84.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
6.8 | 101.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
6.5 | 6.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
6.2 | 99.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
5.5 | 76.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
5.1 | 71.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
4.9 | 48.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.5 | 49.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
4.5 | 49.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
4.3 | 12.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.0 | 43.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
3.5 | 38.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
3.4 | 145.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.2 | 3.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
3.2 | 101.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
3.1 | 70.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.0 | 56.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.8 | 39.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
2.8 | 28.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
2.8 | 16.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
2.7 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.7 | 32.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
2.6 | 33.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
2.6 | 2.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
2.5 | 17.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.5 | 5.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.3 | 29.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.1 | 17.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.1 | 2.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.9 | 100.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.9 | 41.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.8 | 20.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.8 | 32.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.8 | 23.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.8 | 34.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.8 | 25.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.8 | 8.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.7 | 27.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.7 | 24.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.7 | 11.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.6 | 20.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.5 | 1.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.4 | 23.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 25.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.4 | 2.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.4 | 5.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 16.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.4 | 22.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.3 | 25.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.3 | 13.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.3 | 5.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
1.3 | 18.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.3 | 46.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.2 | 4.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.2 | 4.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.2 | 20.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.2 | 33.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.2 | 9.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.2 | 12.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.2 | 10.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.1 | 4.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.1 | 3.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.0 | 19.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
1.0 | 4.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 13.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.9 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 17.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.9 | 13.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 1.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 12.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.8 | 9.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.8 | 4.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.8 | 3.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 0.8 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.7 | 3.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 11.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 30.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.7 | 1.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.7 | 19.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 12.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.7 | 11.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 4.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 7.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 7.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 5.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.6 | 5.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 11.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 6.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 6.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 6.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 4.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 6.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 6.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 30.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 9.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 0.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.5 | 4.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 15.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 1.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.4 | 4.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 4.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 5.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 3.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 8.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 0.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.4 | 3.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 3.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.3 | 5.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 0.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 4.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 16.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.3 | 2.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 2.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 2.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 3.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 9.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 21.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |